Use of our content for AI purposes
Requests to use our content for AI purposes in the UK and internationally are subject to an approval process, licensing arrangement and a fee (for international use).
If you want to use our content for AI purposes, you must complete the permission to use NICE content for artificial intelligence (AI) purposes form.
Complete content
Get permission to publish, share, translate and adapt our content. You can also host the entire NICE guidance library through the use of our syndication service.
Adaptation
Our adaptation licensing allows you to reuse, modify, translate and combine our content with other third-party content to create your own derivative products provided you adhere to established international protocols.
Contextualisation
Our NICE International team manages the NICE guideline contextualisation service. Our experts offer consultancy support to contextualise our guidelines to fit the specific needs of your country as an alternative to developing your own guidelines. This consultancy service also offers quality assurance which aims to ensure your guideline contextualisation follows internationally recognised standards of best practice. We can also give permission for you to adapt our guidelines and other products as part of this added value service.
Translation
Should you wish to translate original NICE content without amendment, we will proof your translation as part of our licence with you. Please note we do not proof adapted content in translation though you are free to translate this work if you choose.
Selected extracts
Get permission to use selected NICE content in third-party products such as books, journals, advertising, marketing and training materials and other products.
Use of our COVID-19 content internationally
Our COVID-19 rapid guidelines and evidence summaries are exempt from our overseas reuse application, licence and fee. This means you can:
adopt the guidelines for your own healthcare setting
adapt the guidelines by combining them with your own local content
translate the resultant outputs.
When using content from our COVID-19 rapid guidelines and evidence summaries you must:
make all your outputs reusing NICE content freely available to others
acknowledge the use of NICE content, and link to the source content on our website
only use the NICE logo if the original NICE guidance publication is used in its entirety without including additional content
tell us how our content has been used by emailing [email protected], to support the evaluation and development of our guidance.
We cannot accept responsibility or liability for the use of our content in third party outputs.